90 related articles for article (PubMed ID: 37684173)
21. Unleashing the potential of NOD- and Toll-like agonists as vaccine adjuvants.
Maisonneuve C; Bertholet S; Philpott DJ; De Gregorio E
Proc Natl Acad Sci U S A; 2014 Aug; 111(34):12294-9. PubMed ID: 25136133
[TBL] [Abstract][Full Text] [Related]
22. Innate sensors that regulate vaccine responses.
Georg P; Sander LE
Curr Opin Immunol; 2019 Aug; 59():31-41. PubMed ID: 30978666
[TBL] [Abstract][Full Text] [Related]
23. Trends in adjuvant development for vaccines: DAMPs and PAMPs as potential new adjuvants.
Miyaji EN; Carvalho E; Oliveira ML; Raw I; Ho PL
Braz J Med Biol Res; 2011 Jun; 44(6):500-13. PubMed ID: 21584443
[TBL] [Abstract][Full Text] [Related]
24. Immunological Mechanism and Clinical Application of PAMP Adjuvants.
Yan Y; Yao D; Li X
Recent Pat Anticancer Drug Discov; 2021; 16(1):30-43. PubMed ID: 33563182
[TBL] [Abstract][Full Text] [Related]
25. Synthetic Toll-like receptor agonists for the development of powerful malaria vaccines: a patent review.
Kaur A; Kannan D; Mehta SK; Singh S; Salunke DB
Expert Opin Ther Pat; 2018 Nov; 28(11):837-847. PubMed ID: 30280939
[TBL] [Abstract][Full Text] [Related]
26. Immunobiology of Carbohydrates: Implications for Novel Vaccine and Adjuvant Design Against Infectious Diseases.
Stefanetti G; Borriello F; Richichi B; Zanoni I; Lay L
Front Cell Infect Microbiol; 2021; 11():808005. PubMed ID: 35118012
[TBL] [Abstract][Full Text] [Related]
27. Glycovaccinology: The design and engineering of carbohydrate-based vaccine components.
Hulbert SW; Desai P; Jewett MC; DeLisa MP; Williams AJ
Biotechnol Adv; 2023 Nov; 68():108234. PubMed ID: 37558188
[TBL] [Abstract][Full Text] [Related]
28. Targeting Syk-Card9-activating C-type lectin receptors by vaccine adjuvants: findings, implications and open questions.
Lang R; Schoenen H; Desel C
Immunobiology; 2011 Nov; 216(11):1184-91. PubMed ID: 21742403
[TBL] [Abstract][Full Text] [Related]
29. Carbohydrate-based vaccine adjuvants - discovery and development.
Hu J; Qiu L; Wang X; Zou X; Lu M; Yin J
Expert Opin Drug Discov; 2015 Oct; 10(10):1133-44. PubMed ID: 26372693
[TBL] [Abstract][Full Text] [Related]
30. Bacterial Protein Toll-Like-Receptor Agonists: A Novel Perspective on Vaccine Adjuvants.
Kumar S; Sunagar R; Gosselin E
Front Immunol; 2019; 10():1144. PubMed ID: 31191528
[TBL] [Abstract][Full Text] [Related]
31. Vaccine adjuvants: Tailoring innate recognition to send the right message.
Lavelle EC; McEntee CP
Immunity; 2024 Apr; 57(4):772-789. PubMed ID: 38599170
[TBL] [Abstract][Full Text] [Related]
32. Vaccine adjuvants: mechanisms and platforms.
Zhao T; Cai Y; Jiang Y; He X; Wei Y; Yu Y; Tian X
Signal Transduct Target Ther; 2023 Jul; 8(1):283. PubMed ID: 37468460
[TBL] [Abstract][Full Text] [Related]
33. Flagellin as a vaccine adjuvant.
Cui B; Liu X; Fang Y; Zhou P; Zhang Y; Wang Y
Expert Rev Vaccines; 2018 Apr; 17(4):335-349. PubMed ID: 29580106
[TBL] [Abstract][Full Text] [Related]
34. Recent Advances in the Development of Toll-like Receptor Agonist-Based Vaccine Adjuvants for Infectious Diseases.
Yang JX; Tseng JC; Yu GY; Luo Y; Huang CF; Hong YR; Chuang TH
Pharmaceutics; 2022 Feb; 14(2):. PubMed ID: 35214155
[TBL] [Abstract][Full Text] [Related]
35. Bioconjugation Approaches to Producing Subunit Vaccines Composed of Protein or Peptide Antigens and Covalently Attached Toll-Like Receptor Ligands.
Xu Z; Moyle PM
Bioconjug Chem; 2018 Mar; 29(3):572-586. PubMed ID: 28891637
[TBL] [Abstract][Full Text] [Related]
36. Immunological Principles Guiding the Rational Design of Particles for Vaccine Delivery.
Gause KT; Wheatley AK; Cui J; Yan Y; Kent SJ; Caruso F
ACS Nano; 2017 Jan; 11(1):54-68. PubMed ID: 28075558
[TBL] [Abstract][Full Text] [Related]
37. Glycans as Vaccine Antigens and Adjuvants: Immunological Considerations.
Zimmermann S; Lepenies B
Methods Mol Biol; 2015; 1331():11-26. PubMed ID: 26169732
[TBL] [Abstract][Full Text] [Related]
38. Polysaccharides: Candidates of promising vaccine adjuvants.
Li P; Wang F
Drug Discov Ther; 2015 Apr; 9(2):88-93. PubMed ID: 25994059
[TBL] [Abstract][Full Text] [Related]
39. Unmet needs in modern vaccinology: adjuvants to improve the immune response.
Leroux-Roels G
Vaccine; 2010 Aug; 28 Suppl 3():C25-36. PubMed ID: 20713254
[TBL] [Abstract][Full Text] [Related]
40. Innate receptors for adaptive immunity.
Michallet MC; Rota G; Maslowski K; Guarda G
Curr Opin Microbiol; 2013 Jun; 16(3):296-302. PubMed ID: 23659869
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
